A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the first trial to flow out of thousands of lawsuits blaming injuries on the blood thinner Xarelto.
Fourth Multi-Million Dollar Verdict Against J&J in Talcum Powder Cancer Case
Johnson & Johnson was ordered by a Missouri jury to pay over $110 million to a Virginia woman who says she developed ovarian cancer after decades of using of its talc-based products for feminine hygiene.
SCOTUS: GM Can’t Limit Pre-Bankruptcy Ignition Switch Claims
By declining to review a lower-court ruling, the justices cleared the way for plaintiffs to proceed with hundreds of claims over deaths or injuries that occurred before General Motors declared bankruptcy.
Drug Company Lawyers try to Blame Plaintiffs’ Lawyer Ads for Adverse Xarelto Outcomes
The first bellwether trial over blood thinner Xarelto began on Monday in New Orleans-but it's not just your ordinary case involving a pharmaceutical drug.
Report: Depakote Linked to 4,100 Birth Defect Cases
Sanofi epilepsy drug is linked to up 4,100 cases of birth defects
Xarelto Maker Seeks Discovery on Third Party Litigation Funding
Defendant drug companies in the Xarelto mass tort want to know how the plaintiffs are funding their lawsuits.
Risperdal Filings Up After J&J Cancels Tolling Agreements Following Massive Verdicts
Records from the Philadelphia County Court of Common Pleas reveal more than 3,000 new Risperdal lawsuits were filed in the first three months of 2017, driving up the total number of filings in this mass tort program to more than 5,500.
Former FBI Director to Oversee Takata Restitution Fund
A federal judge in Detroit said he plans to name former FBI director Robert Mueller to oversee nearly $1 billion in Takata Corp restitution funds as part of a U.S. Justice Department settlement.
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 29
- Next Page »